BTO brings two projects to BioVaria

Our business developers will present the two projects "3D-printed polymer scaffolds in bone regeneration" and "Genetic expression of Neosaxitoxin for pain modulation" at the yearly conference BioVaria, that will find place in Munich, Germany 22. - 23. May.

BioVaria is Europe’s leading marketplace for life-science inventions, and the conference attracts numerous decision makers from industry and venture capital, looking for cutting-edge academic projects.

BioVaria brings together European research institutions across national borders in order to improve the transfer of their research results into application. Europe’s most established technology transfer organizations join to present their most promising projects from academia to decision makers from international industry.

It is considered a must-join event for innovation scouts and business developers from the international biopharmaceutical industry looking for in-licensing and collaboration opportunities, and for venture capitalists looking for high-potential start-ups or IP assets to complement their investment portfolios.

Projects at the conference

BTO is one of the technology transfer partners of the event, and we will present two projects on the conference.

The project “3D-printed polymer scaffolds in bone regeneration” are replacing larger bone fragments with personalized, mechanically resistant scaffold instantly interacting with surrounding tissues. Read the project presentation at BioVaria’s webpage, and find more information about the 3D-project at our webpage.

The second project that will be presented at BioVaria is “Genetic expression of Neosaxitoxin for pain modulation”,  that has developed a first in class technology to express the Neosaxitoxin biosynthetic pathway. You can read the project presentation at BioVaria’s webpage.

Related posts

Featured image for the post BioVaria and BTO partner up
18.12.2014
BioVaria and BTO partner up

The 8th Biovaria is to be held on 11th May 2015 in Munich. This is a must-join event for innovation scouts and business developers from the international biopharmaceutical industry looking for in-licensing and collaboration opportunities, and for venture capitalists looking for high-potential start-ups or IP assets to complement their investment portfolios. BioVaria 2015 is organised by Ascenion and its partners.…

Read more
Featured image for the post BTO attended at BioVaria in Munich last week
10.06.2013
BTO attended at BioVaria in Munich last week

This year, technology transfer professionals and scientists representing 24 research institutes and universities in 14 European countries presented 40 commercial opportunities. These ranged from potential therapeutics and diagnostics to platform technologies. In addition, business developers from Bayer Pharma, Novo Nordisk, MSD and Boehringer Ingelheim presented their inlicensing needs. Altogether, about 170 delegates attended. This year also saw a Spin-off Panel…

Read more
Featured image for the post Introduces innovative treatment to Europe
12.04.2016
Introduces innovative treatment to Europe

On 17 May 2016, dealmakers and investors from the international biopharmaceutical industry will come together in Munich with Europe’s leading life-science researchers, entrepreneurs and technology transfer professionals to initiate partnerships for the development of high-potential academic projects. BTO and 12 further technology transfer organisations from across Europe will present a total of 40 peer-selected technologies, including innovative diagnostic and therapeutic…

Read more
Featured image for the post “Europe’s Next Top Technologies”
22.05.2014
“Europe’s Next Top Technologies”

At BioVaria, decision makers from the biopharmaceutical and medtech industries gathered in Munich with leading scientists and technology transfer professionals to learn about the hottest life-science innovations from universities and research institutes across Europe and initiate co-development partnerships. The conference, organized by Ascenion and ten further technology transfer organizations, featured a total of 40 licensing opportunities: diagnostic and therapeutic projects…

Read more